Skip to main content
Log in

Increase in cost burden of RSV hospitalisation in infants in USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 US dollars

Reference

  • Fergie J, et al. Respiratory Syncytial Virus and All-Cause Bronchiolitis Hospitalizations Among Preterm Infants Using the Pediatric Health Information System (PHIS). Journal of Infectious Diseases : 12 Jul 2020. Available from: URL: http://doi.org/10.1093/infdis/jiaa435

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Increase in cost burden of RSV hospitalisation in infants in USA. PharmacoEcon Outcomes News 859, 19 (2020). https://doi.org/10.1007/s40274-020-7028-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7028-6

Navigation